Vyne Therapeutics Inc. Revenue 2016–2025
Vyne Therapeutics Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Vyne Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 86000, a 57.43% decrease year-over-year.
- Vyne Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 478000, a 12.29% decrease year-over-year.
- Vyne Therapeutics Inc. annual revenue for 2025 was 570000, a 13.77% increase from 2024.
- Vyne Therapeutics Inc. annual revenue for 2024 was 501000, a 18.16% increase from 2023.
- Vyne Therapeutics Inc. annual revenue for 2023 was 424000, a 11.11% decrease from 2022.
- Vyne Therapeutics Inc. annual revenue for 2022 was 477000.
Vyne Therapeutics Inc. (VYNE) — Frequently Asked Questions
Vyne Therapeutics Inc. (VYNE) is a publicly traded US company. It has a market capitalization of $28M. In fiscal 2025 it reported revenue of $570,000 and net income of -$26M. Explore VYNE's stock price, financial statements, earnings history, margins and key ratios below.
What is Vyne Therapeutics Inc.'s market cap?
Vyne Therapeutics Inc. (VYNE) has a market capitalization of $28M.
What is the VYNE stock price?
VYNE trades at $0.66 (+0.15% on the day).
How much revenue does Vyne Therapeutics Inc. make?
Vyne Therapeutics Inc. reported revenue of $570,000 in fiscal 2025.
Is VYNE profitable?
In fiscal 2025, Vyne Therapeutics Inc. reported net income of -$26M.